We recently updated our Privacy Notice and Terms of Use.
Med-IQ
Evolving Strategies for the Prevention of HIV in the Federal Healthcare Setting
Print Publication Print Publication

Evolving Strategies for the Prevention of HIV in the Federal Healthcare Setting


Released:
8/3/18
Expires:
8/2/19

Maximum Credits:

1.0
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

Print Publication Print Publication
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.
Released:
8/3/18

Expires:
8/2/19

Maximum Credits:
1.0
Print Publication Print Publication
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

Released:
8/3/18
Expires:
8/2/19


Maximum Credits:
1.0


Overview: This accredited CME/CE/CPE publication discusses the Veterans Health Administration and Department of Defense HIV-prevention goals outlined in the 2010 and 2015 National HIV/AIDS Strategy for the United States, reviews the epidemiology of HIV acquisition in various federal healthcare settings, explores methods for engaging patients in nonjudgmental conversations about their sexual health, and presents strategies for identifying candidates for pre-exposure prophylaxis for HIV prevention.

CME Information:

Faculty
Jamie P. Morano, MD, MPH
Associate Professor, Division of Infectious Diseases and International Medicine
University of South Florida Morsani College of Medicine
USF College of Public Health, Department of Health Policy and Management
Tampa, FL
 
Puja Van Epps, MD
Assistant Professor, Division of Infectious Diseases & HIV Medicine
Case Western Reserve University School of Medicine
Cleveland, OH

Activity Planners
Stephanie Larson, PhD
Clinical Content Manager
Med-IQ
Baltimore, MD
 
Laura Rafferty, ELS
Managing Editor
Med-IQ
Baltimore, MD
 
Samantha Gordon
CME Specialist
Med-IQ
Baltimore, MD
 
Kathryn Schaefer, MSN, RN, CPHRM
Senior Manager, Accreditation and Compliance
Med-IQ
East Lansing, MI
 
Writer
Katherine Kahn                                           
Holyoke, MA
 
Learning Objectives
Upon completion, participants should be able to:

  • Apply a nonjudgmental approach to routinely taking a sexual history to determine individual patients’ HIV-prevention needs
  • Describe key elements of a guideline-based approach to implementing PrEP for patients at substantial risk of HIV

Target Audience
This activity is intended for physicians, nurses, nurse practitioners, physician assistants, pharmacists, and other healthcare professionals in the federal healthcare system. 

Statement of Need
Although substantial progress has been made over the last 3 decades in the prevention and treatment of HIV, nearly 40,000 persons were newly diagnosed with HIV in the United States in 2016. In the same year, more than 28,000 veterans living with HIV received care at Veterans Health Administration (VHA) medical facilities, making the VHA the largest single provider of HIV care in the country. Both the VHA and the Department of Defense (DoD) support high clinical standards for preventing HIV transmission, especially in high-risk groups, and improving access to HIV care for veterans and active duty servicemembers. Clinicians in the VHA and Military Health System within the DoD may find it challenging to identify patients at high risk of HIV and implement strategies to help prevent HIV infection. It is imperative to provide these medical professionals with tools to support their efforts to reduce HIV transmission among servicemembers and veterans, including methods for engaging patients in nonjudgmental conversations about their sexual health, identifying patients who are most likely to benefit from pre-exposure prophylaxis (PrEP), initiating PrEP, and providing follow-up care.

Providership Statement
Provided by Med-IQ.

Accreditation/Designation Statements
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Med-IQ designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Med-IQ is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
 
This nursing activity has been approved for up to 1.0 contact hour.

ACPEMed-IQ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hour (0.1 CEUs) of credit for pharmacists. ACPE # 0476-0000-18-004-H01-P. This knowledge-based activity is designed for all pharmacists.

Nurse practitioners, physician assistants, and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.

Medium/Method of Participation
This CME/CE/CPE activity consists of a 1.0-credit publication. To receive credit, complete the pre-survey, read the introductory CME/CE/CPE material, read the publication, and complete the post-survey, evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
 
Initial Release Date: August 3, 2018
Expiration Date: August 2, 2019
Estimated Time to Complete This Activity: 1 hour
 
Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
 
Disclosure Statement
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation. 
 
Jamie P. Morano, MD, MPH
Contracted research: Amgen, Bristol-Myers Squibb
Other (USF Clinical Trials Site grant recipient): Gilead Sciences, Inc., Merck & Co., Inc., ViiV Healthcare
 
Puja Van Epps, MD, has indicated no real or apparent conflicts.

The writer, peer reviewers, and activity planners have no financial relationships to disclose.

Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
 
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.

Contact Information        
For questions or comments about this activity, please contact Med-IQ.
Call (toll-free) 866 858 7434 or email info@med-iq.com.            
                     
Hardware/Software Requirements
Operating System
Microsoft Windows® 8, Windows 7
Mac OS 10.7 (Lion) or newer

Browser
Microsoft Internet Explorer 8.0 or later
Mozilla Firefox - latest version
Download: http://www.mozilla.org/en-US/firefox/new/
 
Google Chrome - latest version
Download: http://www.google.com/chrome
 
Apple Safari - latest version
Download: http://www.apple.com/safari/download/

PDF Viewer
Adobe Acrobat Reader® or Adobe Reader
Download: http://get.adobe.com/reader/

Adobe Flash Player
Adobe Flash Player 9 or later
Download: http://get.adobe.com/flashplayer/ 
 
For technical support, go to http://www.med-iq.com/index.cfm?fuseaction=content.support.

ADA Statement
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.
 
Disclaimer
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy policy, please visit: www.med-iq.com/privacy-policy.html.

Acknowledgment of Commercial Support
This activity is supported by an educational grant from Gilead Sciences, Inc.

Copyright
© 2018 Med-IQ, Inc.

 

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or email info@med-iq.com. For technical assistance, please refer to our support manual.